Medication adherence, costs, and ER visits of nurse practitioner and primary care physician patients: Evidence from three cohorts of Medicare beneficiaries.

Ulrike Muench, Chaoran Guo, Cindy Thomas, Jennifer Perloff
Author Information
  1. Ulrike Muench: Department of Social and Behavioral Sciences, School of Nursing, University of California San Francisco, San Francisco, California. ORCID
  2. Chaoran Guo: Department of Economics, The Chinese University of Hong Kong, Hong Kong, China.
  3. Cindy Thomas: The Heller School, Brandeis University, Waltham, Massachusetts.
  4. Jennifer Perloff: The Heller School, Brandeis University, Waltham, Massachusetts. ORCID

Abstract

OBJECTIVE: To compare medication adherence, cost, and utilization in Medicare beneficiaries attributed to nurse practitioners (NP) and primary care physicians (PCP).
DATA: Medicare Part A, B, and D claims and beneficiary summary file data, years 2009-2013.
STUDY DESIGN: We used propensity score-weighted analyses combined with logistic regression and generalized estimating equations to test differences in good medication adherence (proportion of days covered (PDC >0.8); office-based and specialty care costs; and ER visits.
DATA EXTRACTION: Beneficiaries with prescription claims for anti-diabetics, renin-angiotensin system antagonists (RASA), or statins.
PRINCIPAL FINDINGS: There were no differences in good medication adherence (PDC >0.8) between NP and PCP attributed beneficiaries taking anti-diabetics or RASA. Beneficiaries taking statins had a slightly higher probability of good adherence when attributed to PCPs (74.6% vs 75.5%; P < 0.05). NP attributed beneficiaries had lower office-based and specialty care costs and were less likely to experience an ER visit across all three medication cohorts (P < 0.01).
CONCLUSIONS: Examining the impact of NP and PCP provided care on outcomes beyond the primary care setting is important to the Medicare program in general but will also help practices seeking to meet benchmarks under alternative payment models that incentivize higher quality and lower costs.

Keywords

References

  1. J Am Board Fam Med. 2006 Sep-Oct;19(5):478-86 [PMID: 16951297]
  2. Health Aff (Millwood). 2011 Jan;30(1):91-9 [PMID: 21209444]
  3. Med Care Res Rev. 2004 Sep;61(3):332-51 [PMID: 15358970]
  4. Ann Pharmacother. 2009 Jan;43(1):36-44 [PMID: 19126828]
  5. Health Serv Res. 2019 Feb;54(1):187-197 [PMID: 30284237]
  6. Pediatrics. 2013 Oct;132(4):730-40 [PMID: 23999953]
  7. J Health Econ. 2001 Jul;20(4):461-94 [PMID: 11469231]
  8. SSM Popul Health. 2016 Dec;2:123-129 [PMID: 27152319]
  9. Curr Opin Cardiol. 2006 Jul;21(4):310-5 [PMID: 16755199]
  10. Nurs Econ. 2011 Sep-Oct;29(5):230-50; quiz 251 [PMID: 22372080]
  11. Pharmacotherapy. 2018 Apr;38(4):417-427 [PMID: 29457258]
  12. Am Econ Rev. 2011 May;101(3):382-386 [PMID: 25067840]
  13. JAMA. 2000 Jan 5;283(1):59-68 [PMID: 10632281]
  14. J Am Geriatr Soc. 2004 May;52(5):675-84 [PMID: 15086645]
  15. Health Serv Res. 2016 Aug;51(4):1407-23 [PMID: 26707840]
  16. Arch Intern Med. 2005 Aug 8-22;165(15):1749-55 [PMID: 16087823]
  17. J Adv Nurs. 2011 Jan;67(1):117-26 [PMID: 21073502]
  18. Respir Med. 2011 Mar;105(3):435-41 [PMID: 20880687]
  19. Am J Manag Care. 2010 Aug;16(8):568-76 [PMID: 20712390]
  20. Appl Health Econ Health Policy. 2014 Jun;12(3):335-46 [PMID: 24756319]
  21. Multivariate Behav Res. 2011 May;46(3):399-424 [PMID: 21818162]
  22. Int J Nurs Stud. 2014 Jul;51(7):1048-61 [PMID: 24398118]
  23. Arch Psychiatr Nurs. 2003 Jun;17(3):101-7 [PMID: 12840802]
  24. Med Care. 1998 Jan;36(1):8-27 [PMID: 9431328]
  25. Nurse Pract. 2004 Jan;29(1):26-31 [PMID: 14726787]
  26. BMJ. 2000 Apr 15;320(7241):1048-53 [PMID: 10764367]
  27. Ann Intern Med. 2012 Dec 4;157(11):785-95 [PMID: 22964778]
  28. Patient Educ Couns. 2009 May;75(2):185-91 [PMID: 19013740]
  29. Med Care. 2018 Jun;56(6):484-490 [PMID: 29613873]
  30. J Am Geriatr Soc. 2015 Oct;63(10):1980-8 [PMID: 26480967]
  31. Health Serv Res. 2017 Feb;52 Suppl 1:481-507 [PMID: 28127767]

Grants

  1. /National Council of State Boards of Nursing

MeSH Term

Cohort Studies
Emergency Service, Hospital
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Male
Medicare
Nurse Practitioners
Physicians, Primary Care
United States
Assessment of Medication Adherence

Chemicals

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents

Word Cloud

Created with Highcharts 10.0.0careadherenceMedicarecostsmedicationbeneficiariesattributedNPprimaryPCPgoodERnurseclaimsdifferencesPDC>08office-basedspecialtyvisitsBeneficiariesanti-diabeticsRASAstatinstakinghigherP < 0lowerthreecohortsOBJECTIVE:comparecostutilizationpractitionersphysiciansDATA:PartBDbeneficiarysummaryfiledatayears2009-2013STUDYDESIGN:usedpropensityscore-weightedanalysescombinedlogisticregressiongeneralizedestimatingequationstestproportiondayscoveredDATAEXTRACTION:prescriptionrenin-angiotensinsystemantagonistsPRINCIPALFINDINGS:slightlyprobabilityPCPs746%vs755%05lesslikelyexperiencevisitacross01CONCLUSIONS:ExaminingimpactprovidedoutcomesbeyondsettingimportantprogramgeneralwillalsohelppracticesseekingmeetbenchmarksalternativepaymentmodelsincentivizequalityMedicationpractitionerphysicianpatients:Evidencehealth

Similar Articles

Cited By (14)